Results 11 to 20 of about 10,817 (231)
Non-Langerhans cell histiocytosis associated with lymphocyte-predominant Hodgkin's disease
Clinical and Experimental Dermatology, 1999 We report a 74-year-old man who presented with a rash on the trunk showing clinical and histological features of non-Langerhans cell histiocytosis. Two years after presentation he developed weight loss, lymphadenopathy and hepatosplenomegaly; a diagnosis
Sviland, L. +3 more
core +5 more sources
American Journal of Surgical Pathology, 2008 Langerin is a type II transmembrane C-type lectin associated with the formation of Birbeck granules in Langerhans cells. Langerin is a highly selective marker for Langerhans cells and the lesional cells of Langerhans cell histiocytosis. Although Langerin
Chu, Peiguo G. +2 more
core +3 more sources
Langerhans cell and non Langerhans cell histiocytosis: So different?
, 2007 The Author reports the clinical and laboratory criteria that do not support the strict distinction between Langerhans cell and non Langerhans cell histiocytosis as reported in the relevant ...
C. Gelmetti
core +2 more sources
Clinical, Cosmetic and Investigational Dermatology, 2022 Raden Mohamad Rendy Ariezal Effendi, Trustia Rizqandaru, Renata Yuliasari, Srie Prihianti Gondokaryono, Inne Arline Diana, Reiva Farah Dwiyana Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr.
Effendi RMRA +5 more
doaj +3 more sources
Intra-arterial Melphalan for Neurologic Non-Langerhans Cell Histiocytosis [PDF]
Neurology, 2021 Histiocytic neoplasms are rare hematologic disorders characterized by pathologic infiltration of activated histiocytes in affected tissues. The treatment of histiocytic neoplasms, including Langerhans cell histiocytosis (LCH) and non-LCH, has advanced in recent years owing to targeted kinase inhibitors (BRAF and MEK) as patients with somatic mutations ...
Jasmine H. Francis +10 more
openaire +2 more sources
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
A case of disseminated extranodal Rosai–Dorfman disease diagnosed by skin manifestations
Journal of Cutaneous Immunology and Allergy, 2023 Rosai–Dorfman disease (RDD) is a rare non‐Langerhans cell histiocytosis that was first described as sinus histiocytosis with massive lymphadenopathy by Rosai and Dorfman in 1969.
Shintaro Saito +3 more
doaj +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021 restriction
Yeongjoo, Oh +2 more
openaire +3 more sources
Non-Langerhans cell histiocytosis in a child with Kawasaki disease
BMJ Case Reports, 2009 Polymorphous skin rashes are one of the major presentations in children with Kawasaki disease. This report describes an unusual presentation of a skin rash (non-Langerhans cell histiocytosis) in a 4-month-old baby with resistance to intravenous immunoglobulin (IVIG) treatment and coronary artery dilatation.
Ho-Chang, Kuo +6 more
openaire +3 more sources
High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis [PDF]
Blood, 2017 Key Points Some 10.1% of adults with non–Langerhans cell histiocytosis have a concomitant myeloid neoplasm with each often harboring distinct mutations. The presence of distinct kinase mutations in histiocytosis and myeloid neoplasms resulted in discordant responses to targeted therapy.
Papo, Matthias +22 more
openaire +3 more sources